0001193125-16-487133.txt : 20160301 0001193125-16-487133.hdr.sgml : 20160301 20160301102834 ACCESSION NUMBER: 0001193125-16-487133 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160301 ITEM INFORMATION: Other Events FILED AS OF DATE: 20160301 DATE AS OF CHANGE: 20160301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INVENTIV HEALTH INC CENTRAL INDEX KEY: 0001089473 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 522181734 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-30318 FILM NUMBER: 161471594 BUSINESS ADDRESS: STREET 1: ONE VAN DE GRAAFF DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 732-537-4800 MAIL ADDRESS: STREET 1: ONE VAN DE GRAAFF DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803 FORMER COMPANY: FORMER CONFORMED NAME: VENTIV HEALTH INC DATE OF NAME CHANGE: 19990810 FORMER COMPANY: FORMER CONFORMED NAME: SNYDER HEALTHCARE SERVICES INC DATE OF NAME CHANGE: 19990624 8-K 1 d141827d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

March 1, 2016

Date of Report (Date of earliest event reported)

 

 

inVentiv Health, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

(State or other jurisdiction of incorporation)

 

000-30318  

52-2181734

(Commission File Number)   (IRS Employer Identification No.)
1 Van De Graaff Drive  
Burlington, Massachusetts   01803
(Address of principal executive offices)   (Zip Code)

(800) 416-0555

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 8.01 Other Events

inVentiv Health, Inc. (the “Company”) will hold a conference call at 2:00PM Eastern Time on March 24, 2016, during which it will discuss the Company’s financial results for the fourth quarter of 2015.

The U.S. dial-in for the call is (877) 498-6434 ((929) 387-3953 for non-U.S. callers) and the passcode is 60136249. A replay of the conference call will be available until March 31, 2016 by dialing (855) 859-2056 ((404) 537-3406 for non-U.S. callers) and the passcode is 60136249.

The information furnished on this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  INVENTIV HEALTH, INC.
By:   /s/ Jonathan E. Bicknell
  Name: Jonathan E. Bicknell
  Title:   Chief Financial Officer

Date: March 1, 2016

 

3